 A, Becquemin JP,
et al. Long-term outcomes of stenting and endarterectomy for
symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data. Lancet Neurol 2019;18:348-56.
39. Nallamothu BK, Gurm HS, Ting HH, Goodney PP, Rogers MA,
Curtis JP, et al. Operator experience and carotid stenting outcomes
in Medicare beneﬁciaries. JAMA 2011;306:1338-43.
40. Nolan BW, De Martino RR, Goodney PP, Schanzer A, Stone DH,
Butzel D, et al. Comparison of carotid endarterectomy and stenting
in real world practice using a regional quality improvement registry.
J Vasc Surg 2012;56:990-6.
41. Hicks CW, Nejim B, Locham S, Aridi HD, Schermerhorn ML,
Malas MB. Association between Medicare high-risk criteria and
outcomes after carotid revascularization procedures. J Vasc Surg
2018;67:1752-61.e2.
42. Leal I, Orgaz A, Flores Á, Gil J, Rodríguez R, Peinado J, et al.
A diffusion-weighted magnetic resonance imaging-based study of
transcervical carotid stenting with ﬂow reversal versus transfemoral
ﬁlter protection. J Vasc Surg 2012;56:1585-90.
43. Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J,
Nederkoorn PJ, et al. New ischaemic brain lesions on MRI after
stenting or endarterectomy for symptomatic carotid stenosis: a
substudy of the International Carotid Stenting Study (ICSS).
Lancet Neurol 2010;9:353-62.
44. Kwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, et al.
Results of the ROADSTER multicenter trial of transcarot